The pattern of response to antiviral therapy may change after liver transplantation in patients with chronic HCV infection

被引：0
|
作者：
Feliu, A [1 ]
Carrion, JA [1 ]
Massaguer, A [1 ]
Garcia-Retortillo, M [1 ]
Gonzalez, P [1 ]
Costa, J [1 ]
Martinez-Bauer, E [1 ]
Sanchez-Tapias, JM [1 ]
Forns, X [1 ]
机构：
[1] Hosp Clin Barcelona, Liver Unit, IDIBAPS, Barcelona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2005年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [21] Sustained virological response of 65% in patients treated with combination antiviral therapy for recurrent HCV following liver transplantation.
    Al Alwan, AJ
    Girgrah, N
    McQuarrie, B
    Cattral, M
    Baker, N
    Greig, PD
    Humar, A
    Grant, D
    McGilvray, I
    Levy, GA
    Lilly, L
    HEPATOLOGY, 2004, 40 (04) : 359A - 359A
  • [22] The use of antiviral monotherapy and combination therapy for patients with hepatitis B virus infection after liver transplantation
    Fischer, L
    Sterneck, M
    Meier, D
    Zöllner, B
    Rogiers, X
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (06) : 2283 - 2284
  • [23] Chemokine changes during direct antiviral agents (DAA) therapy in patients with HCV infection or reinfection after liver transplantation: preliminary insights on their possible correlates
    Colucci, G.
    Donato, M. F.
    D'Ambrosio, R.
    Invernizzi, F.
    Degasperi, E.
    Perbellini, R.
    Lunghi, G.
    Uceda, S.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E66 - E66
  • [24] Antiviral therapy in patients with occult HCV infection.
    Pardo, M
    Castillo, I
    Rodríguez-Iñigo, E
    Pérez-Mota, A
    Carreño, V
    HEPATOLOGY, 2005, 42 (04) : 658A - 658A
  • [25] THE IMPACT OF ANTIVIRAL THERAPY ON FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION (LT)
    De Martin, Eleonora
    Senzolo, Marco
    Boninsegna, Sara
    Russo, Francesco P.
    Gambato, Martina
    Germani, Giacomo
    Vitale, Alessandro
    Zanus, Giacomo
    Brolese, Alberto
    Cillo, Umberto
    Burra, Patrizia
    TRANSPLANT INTERNATIONAL, 2009, 22 : 327 - 327
  • [26] PERIPHERAL NK CELLS IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION DURING INTERFERON-FREE ANTIVIRAL THERAPY
    Zanetto, A.
    Ferrarese, A.
    Shawkat, A.
    Shalaby, S.
    Bergamo, C.
    Franceschet, E.
    Bortoluzzi, I.
    Nadal, E.
    Gambato, M.
    Germani, G.
    Senzolo, M.
    Gringeri, E.
    Zanus, G.
    Boccagni, P.
    Cillo, U.
    Burra, P.
    Russo, F. P.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E46 - E46
  • [27] Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation
    Kawaoka, Tomokazu
    Takahashi, Shoichi
    Kawakami, Yoshiiku
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Hyogo, Hideyuki
    Aikata, Hiroshi
    Ishiyama, Kohei
    Tashiro, Hirotaka
    Ohdan, Hideki
    Tanaka, Junko
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2015, 45 (11) : 1047 - 1054
  • [28] MODIFICATION OF IMMUNE SYSTEM BY CHRONIC HCV INFECTION AND UNIQUE PREDICTORS OF EARLY ACUTE REJECTION AFTER HCV LIVER TRANSPLANTATION VERSUS NON HCV LIVER TRANSPLANTATION
    Koshiba, Takaaki
    Zhao, Xiangdong
    Li, Ying
    Bishop, Alex
    TRANSPLANT INTERNATIONAL, 2013, 26 : 208 - 208
  • [29] TREATMENT FOR RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION
    Guedes, Cassia
    Pousa, Fernanda
    Roma, Joyce
    Gonzalez, Ana Carolina
    Agolia, Luciana
    Enne, Marcelo
    Martinho, Jose Manoel
    Carius, Luciana
    Balbi, Elizabeth
    Pacheco-Moreira, Lucio
    LIVER TRANSPLANTATION, 2009, 15 (07) : S131 - S131
  • [30] Beneficial effects of antiviral therapy in advanced chronic liver disease due to HCV infection: A pilot study
    Kumar, R
    Kumar, S
    Singh, J
    Sharma, BC
    Sarin, SK
    GASTROENTEROLOGY, 2003, 124 (04) : A767 - A768
12345